Pro-forma figures for 6 month

RNS Number : 2623M
Smiths Group PLC
27 January 2009
 



27 January 2009


Smiths Group plc - Pro-forma figures for six months to 31 January 2008


In June 2008, Smiths Group announced a reorganisation of its corporate centre and divisional headquarters to improve customer focus and reduce cost. The Specialty Engineering division was disbanded on 31 July 2008 and its three constituent businesses - John Crane, Smiths Interconnect and Flex-Tek - will be reported as separate divisions from the start of the current financial year. In addition, we announced that we will report the corporate centre costs separately in order to provide greater clarity to the underlying margins of the divisions and provide a clear incentive to minimise corporate costs.


The financial results for the six months to 31 January 2009 will be reported on this basis. The pro-forma results for the comparative period are set out below and are subject to review as part of the process for reporting the half year results.


Pro-forma figures for six months to 31 January 2008

 

 
 
Headline
 
 
operating
 
Sales
profit
 
£m
£m
 
 
 
Smiths Detection
222.0
35.0
John Crane
282.8
40.7
Smiths Medical
346.3
66.8
Smiths Interconnect
121.1
23.3
Flex-Tek
99.6
10.5
Marine Systems*
16.0
0.8
Corporate
-
(19.0)
 
1087.8
158.1
 
 
 

*Marine Systems was sold in November 2007.


The results for the six months to 31 January 2009 will be announced on 25 March 2009.


Smiths Group

Smiths is a global technology company listed on the London Stock Exchange. A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs more than 20,000 people in over 50 countries. For more information visit www.smiths.com


Media

Colin McSeveny

+44 (0)7850 884815


Anthony Cardew - Cardew Group

+44 (0)20 7930 0777


Investor Relations 

Peter Durman

+44 (0)7825 145336


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEQLFLKFBEBBL
UK 100

Latest directors dealings